Shimaa Abdelalim Mahmmoud Essa creator Ayatullah Farouk Ahmed Supervisor Shereen Mohamed Fathi Sheir Supervisor Yousry Mahmoud Mostafa Supervisor text theses ua Cairo Shimaa Abdelalim Mahmmoud Essa 2017 monographic eng

print

141 P. : charts , facsimiles , photographs ; 25cm Background: Multiple sclerosis is an Inflammatory and neurodegenerative disease of the central nervous system of unknown reason or definite cure. Purpose: Proposing safe alternative therapies for the early management of multiple sclerosis. Study Design: Repeated measures randomized control trial. Materials and methods: 24 patients with relapsing-remitting multiple Sclerosis, from both sexes completed the study, age 25-45 years; randomly assigned into four groups. Seven patients in the control group (1); received monthly IV infusion of (1g) Solu-Medrol therapy for multiple sclerosis. Six Patients in group (2) received Solu-Medrol plus low intensity laser therapy LILT 850 nm. Six patients in group (3) received Solu-Medrol plus broad band ultraviolet B radiation BB-UVBR (280-320 nm). Five patients in group (4) received Solu-Medrol, scanner LILT and BB-UVBR; all three groups received sessions 3 days/week for 12 sessions. Expanded disability status Scale (EDSS), Fatigue severity scale (FSS), visual evoked potential (VEP), H-reflex latency, and H/M Ratio were assessed pre-treatment, post treatment, 3 months follow up. Results: Statistically significant reduction of fatigue severity FSS was recorded between the four groups post treatment (p=.013) in favor of group (4) and highly significant one (p=.005) at follow up in favor of the group (3) specialized Shimaa Abdelalim Mahmmoud Essa ; Supervised Yousry Mahmoud Mostafa , Shereen Mohamed Fathi Sheir , Ayatullah Farouk Ahmed Thesis (Ph.D.) - Cairo University - National Institute of Laser Enhanced Sciences - Department of Laser Applications in Medicine and Biology Issued also as CD Broad Band Ultraviolet B Radiation Multiple Sclerosis Phototherapy http://172.23.153.220/th.pdf http://172.23.153.220/th.pdf EG-GiCUC 180109 20250223031912.0 eng